Acceptance and Commitment Therapy for the Improvement of Cancer Distress in Patients With Incurable Cancers, ACT-C Trial
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Acceptance and Commitment Therapy, Questionnaire Administration, Telemedicine.
- Who it may be relevant to
- Registry conditions: Malignant Hepatobiliary Neoplasm. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Development of Acceptance and Commitment Therapy for Cancer Distress Among Rural and Urban Patients With Incurable Cancers (ACT-C)
Overview
This clinical trial studies whether Acceptance and Commitment Therapy can be used to help improve cancer distress for patients with hepatobiliary or breast cancers for which no treatment is currently available (incurable). Patients with hepatobiliary cancer (HBC) and breast cancer often experience high levels of distress and reductions in quality of life. Acceptance and Commitment Therapy for incurable cancers (ACT-C) is a behavioral intervention tailored to patients with incurable HBC and breast cancer. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.
Interventions
- Behavioral Acceptance and Commitment Therapy
Attend ACT-C telehealth group sessions - Other Questionnaire Administration
Ancillary studies - Other Telemedicine
Attend ACT-C telehealth group sessions
Primary outcome measures
- Patient satisfaction [Time frame: At 8 weeks]
- Patient session attendance (Feasibility) [Time frame: At 8 weeks]
Eligibility criteria
Inclusion criteria
- Incurable HBC and breast cancer diagnosis
- Age >= 18 years
- Able to provide written informed consent
- Verbally endorse cancer distress
- Access to the internet
- Read and write in English
- Reside in the states of Minnesota
Exclusion criteria
- Other psychological therapy that started =< 2 months prior to prospective enrollment
- Inability to actively participate in and learn from group therapy (e.g., active/uncontrolled psychotic symptoms, neurological condition, personality pathology) as determined by clinical judgement in Behavioral Medicine Program (BMP) consultation. Individual therapy or alternative group therapy will be offered to patients ineligible per this criterion
- Cancer remission
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- Mayo Clinic in Rochester — Rochester
Identifiers
NCT: NCT07124546 · 24-010916